Perceived risk of medicine side effects in users of a patient information website: A study of the use of verbal descriptors, percentages and natural frequencies

British Journal of Health Psychology

Volumn 14, Issue 3, 2009, Pages 579-594

  Knapp, Peter ^a   Gardner, P H ^a   Carrigan, N ^c   Raynor, D K ^a   Woolf, E ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PACLITAXEL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CANCER RESEARCH; CONTROLLED STUDY; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG INFORMATION; FATIGUE; FEMALE; HEARTBURN; HUMAN; INCIDENCE; INFECTION; INTERNET; MALE; MYALGIA; PATIENT INFORMATION; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; VERBAL COMMUNICATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATTITUDE TO HEALTH; CULTURE; DRUG INFORMATION SERVICES; FEMALE; HUMANS; IBUPROFEN; INTERNET; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PACLITAXEL; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEMANTICS; YOUNG ADULT;

EID: 67650996738     PISSN: 1359107X     EISSN: None     Source Type: Journal    
DOI: 10.1348/135910708X375344     Document Type: Article

References (25)

1. Bennett, P. (1998). Communicating about risks to public health: Pointers to good practice. London: Department of Health.
2. Berry, D. C. (2004). Risk, communication and health psychology. Milton Keynes: Open University Press.
3. Berry, D. C., Michas, I. C., & Bersellini, E. (2002). Communicating information about medication side effects: Effects on satisfaction, perceived risk to health, and intention to comply. Psychology and Health, 17, 247-267.
4. Berry, D. C., Gillie, T., & Banbury, S. P. (1995). What do patients want to know about their medicines? An empirical study. Expert Systems with Applications, 8, 419-428.
5. Berry, D. C., Knapp, P., & Raynor, D. K. (2002). Provision of information about drug side effects to patients. The Lancet, 359, 853-854. (Pubitemid 34233761)
6. Berry, D. C., Michas, I. C., Gillie, T., & Forster, M. (1997). What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychology and Health, 12, 467-480. (Pubitemid 127126090)
7. Berry, D. C., Raynor, D. K., & Knapp, P. (2002). Is 15% very common? Informing people about the risks of medicine side effects. International Journal of Pharmacy Practice, 10, 145-151.
8. Berry, D. C., Raynor, D. K., & Knapp, P. (2003). Communicating risk of medication side effects: An empirical evaluation of EU recommended terminology. Psychology, Health and Medicine, 8, 251-263.
9. Berry, D. C., Raynor, D. K., Knapp, P., & Bersellini, E. (2004). Over the counter medicines and the need for immediate action: A further evaluation of European commission recommended wordings for communicating risk. Patient Education and Counselling, 53, 129-134. (Pubitemid 38622057)
10. Bryant, G. D., & Norman, G. R. (1980). Expressions of probability: Words and numbers. New England Journal of Medicine, (7), 302-411.
11. Carrigan, N., Raynor, D. K., & Knapp, P. (2008). Adequacy of patient information on adverse effects: An assessment of patient information leaflets in the UK. Drug Safety, 31, 305-312.
12. Department of Health (2000). The NHS Plan. A Plan for Investment. A plan for Reform. London: Stationery Office.
13. European Commission (1992). EEC Directive 92/27/EEC on labelling of medicinal products for human use and on package leaflets (OJ No. L113 of 30 April 1992).
14. European Commission (1998). A guideline on the readability of the label and package leaflet of medicinal products for human use. EC Pharmaceuticals Committee.
15. European Commission (2006). Draft guideline on the readability of the label and package leaflet of medicinal products for human use (Revision). EC Pharmaceuticals Committee.
16. Gigerenzer, G. (2002). Reckoning with risk. London: Penguin.
17. Gigerenzer, G., & Edwards, A. (2004). Simple tools for understanding risks: From innumeracy to insight. British Medical Journal, 327, 741-744.
18. Hoffrage, U., Gigerenzer, G., Krauss, S., & Martignon, L. (2002). Representation facilitates reasoning: What natural frequencies are and what they are not. Cognition, 84, 343-352. (Pubitemid 34580615)
19. Hoffrage, U., Lindsay, X., Hertwig, X., & Gigerenzer, G. (2000). Communicating statistical information. Science, 290, 2261-2262.
20. Knapp, P., Raynor, D. K., & Berry, D. C. (2004). Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality and Safety in Health Care, 13, 176-180. (Pubitemid 38797502)
21. Medicines and Healthcare products Regulatory Agency [MHRA] (2005). Always read the leaflet - getting the best information with every medicine. (Rep. No. Report of the committee on safety of medicines working group on patient information). London: The Stationery Office.
22. Paling, J. (2003). Strategies to help patients understand risk. British Medical Journal, 327, 745-748. (Pubitemid 37176764)
23. Raynor, D. K., Blenkinsopp, A., Knapp, P., Grime, J., Nicolson, D. J., Pollock, K., et al. (2007). A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment, 11(5), 1-177.
24. Windschitl, P. D., & Wells, G. L. (1996). Measuring psychological uncertainty: Verbal versus numeric methods. Journal of Experimental Psychology: Applied, 2, 343-364. (Pubitemid 126449528)
25. Ziegler, D. K., Mosier, M. C., Buenaver, M., & Okuyemi, K. (2001). How much information about adverse effects of medication do patients want from physicians? Archives of Internal Medicine, 161, 706-713.